• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus

tetano

Editor, Senior Moderator
J Gen Virol. 2014 Jan 6. doi: 10.1099/vir.0.061721-0. [Epub ahead of print]
The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus.
Zhang H, Li X, Guo J, Li L, Chang C, Li Y, Bian C, Xu K, Chen H, Sun B.
Author information
Abstract

Human infection by H7N9 influenza virus was first identified in China in March 2013. As of August 12, 2013, a total of 135 documented cases with 44 fatalities had been reported. Genetic and laboratory analyses of the novel H7N9 viruses isolated from patients indicate that these viruses possess several polymerase gene mutations previously associated with human adaptation and potential pandemic capabilities. However, the function of these mutations in the emergence and pathogenicity of the viruses is not well known. In this study, we demonstrate that the PB2 E627K mutation, which occurs in over 70% of the H7N9 patient isolates, promotes the replication of H7N9 virus by enhancing PB2 polymerase activity and enhances virulence in mice. Our results show the PB2 E627K mutation has played an important role in this H7N9 influenza outbreak and in the pathogenicity of the H7N9 virus.
KEYWORDS:

H7N9, PB2, pathogenicity, polymerase

PMID:
24394699
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24394699
 
Back
Top Bottom